Home
 /
Papers
 /
Microbiology
 /
Antiviral reverse transcriptase–primase synthesizes protein-templated DNA
Preprint
Open access
V1
Top 1% · Validated by QED

Antiviral reverse transcriptase–primase synthesizes protein-templated DNA

Xin-Yi Song, Yushan Xia, Jun-Tao Zhang +4 more
April 2026
 ·
bioRxiv
 ·
DOI 
10.64898/2026.04.18.719102
94
%
Reproducible
QED Impressions
This paper passed independent validation.
QED's automated review checked the evidence supporting each claim, the statistical methods, and whether the results are reproducible from the data provided.

It ranks in the top 1% of preprints assessed in Microbiology this quarter.
Run full QED analysis
Read paper
Save

Why this is interesting

By revealing that a bacterial reverse transcriptase uses protein residues—not nucleic acids—as template for sequence-specific DNA synthesis, this work overturns a core assumption of polymerase biology and exposes an entirely new antiviral defense strategy.

QED claims analysis

Summary

DRT7, a defense-associated reverse transcriptase-primase fusion protein, confers broad-spectrum anti-phage immunity through abortive infection by synthesizing long, protein-primed, palindromic poly(A)/poly(T)-rich duplex-like DNA via an unprecedented mechanism in which the RT domain initiates protein-templated, sequence-specific poly(T) synthesis through an arginine-rich recognition pocket, and iterative handoff between RT and PP domains generates self-complementary ssDNA structures, with the RT-synthesized poly(T) serving as both primer and template for PP-mediated poly(A) extension.

See full analysis
Main Claim 1 –

DRT7 mediates abortive anti-phage defense activated by phage regulator

Supporting evidence

  • Poly(T) elongation switches DRT7 from closed to open dimer
Main Claim 2 –

DRT7 synthesizes protein-primed palindromic poly(A)/poly(T) hairpin ssDNA

Supporting evidence

  • Arginine-rich RT pocket drives protein-templated thymidine-specific poly(T) synthesis
Main Claim 3 –

RT-made poly(T) primes and templates PP poly(A) extension

Supporting evidence

  • PP uses poly(T) template for Watson–Crick poly(A) synthesis
  • Iterative RT–PP cycling generates palindromic poly(A)/poly(T) duplex-like DNA

Abstract

Defense-associated reverse transcriptases (DRTs) are widespread in bacteria, but how multi-domain DRTs containing RT and additional catalytic activities coordinate antiviral defense remains unclear. Here we show that DRT7, which contains both reverse transcriptase (RT) and primase–polymerase (PP) domains, provides broad-spectrum anti-phage immunity through abortive infection and can be activated by a phage-encoded putative transcriptional regulator. Upon activation, DRT7 synthesizes long, protein-primed, palindromic poly(A)/poly(T)-rich duplex-like DNA. Cryo–electron microscopy structures reveal that RT initiates protein-primed, protein-templated, sequence-specific poly(T) synthesis through an arginine-rich recognition pocket without requiring a complementary nucleic acid template, thereby converting DRT7 from an inactive closed dimer to an active open dimer. The RT-produced poly(T) then serves as both primer and template for PP-mediated poly(A) extension, with iterative handoff between RT and PP generating palindromic, alternating poly(A)/poly(T) ssDNA tracts that assemble into fold-back duplex-like DNA. These findings uncover an unexpected antiviral strategy based on protein self-templating, sequence-specific duplex-like DNA synthesis and reveal how coupling RTs with additional catalytic activities expands the functional scope of nucleic acid synthesis pathways.

Related papers

How the QED Score works

QED Score is a validated AI-based quality metric that evaluates life science papers on two dimensions: originality and validity. Each manuscript is anonymized, broken down into its claims and supporting evidence, and examined by specialized AI agents for statistical rigor, consistency across figures, and fit with the existing literature. Scores are percentile ranks, so they're comparable across fields. In blinded tests, expert professors sided with QED Score over journal rank in 75% of decisive cases.
Read the methodology

Free access for academic researchers

Create your free QED account to validate your research, strengthen grant proposals, and uncover scientific insights.
We've sent you an access link.
Please check your inbox.

Didn't get your email? Check your spam folder or reach out to info@qedscience.com

Oops! Something went wrong while submitting the form.
Looking for QED for pharma, biotech or life science organizations?